Titan Spine
Creating Advanced Interbody Fusion Solutions for Cervical and Lumbar Spine Procedures
Creating Advanced Interbody Fusion Solutions for Cervical and Lumbar Spine Procedures
Titan Spine is a biotechnology and medical devices startup that specializes in producing advanced interbody fusion solutions for cervical and lumbar spine procedures. Their product line includes various devices targeting specific spine regions. The company serves patients in the United States and Europe through its dedicated sales force and a network of independent distributors. Established in 2006 by Kevin Gemas and Peter Ullrich, Titan Spine is headquartered in Mequon, Wisconsin, with operations in Laichingen, Germany. The startup recently received a $16.72M Series B investment on 20 November 2018 from Southlake Equity Group. This strategic alliance is a testament to the potential and growth opportunities for Titan Spine in the biotechnology and medical devices industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | $16.72M | 1 |
|
20 Nov 2018 |
| Series B | $15.00M | 1 |
|
08 Jan 2018 |
| Series B | $1.82M | - | 09 Jan 2017 | |
| Venture Round | $9.14M | 1 |
|
01 Jan 2017 |
| Venture Round | $7.88M | 1 |
|
13 Jul 2016 |
No recent news or press coverage available for Titan Spine.
We care about your data, and we'd love to use cookies make your experience better.
